Abstract
A literature review was performed of studies reporting sensitivity and specificity of [18F]fluorodeoxyglucose (FDG) PET from January 1, 2000 to January 1, 2010. PET was found to have higher sensitivity for the detection of osseous metastases when compared to CT, skeletal scintigraphy, whole body MRI and combined conventional imaging modalities. A potential exception is when comparing PET with bone scan in the setting of blastic metastases. PET may be a better indicator of active bony metastases. The efficacy of PET can be increased with fused anatomic imaging.
Original language | English (US) |
---|---|
Pages (from-to) | 281-295 |
Number of pages | 15 |
Journal | PET Clinics |
Volume | 5 |
Issue number | 3 |
DOIs | |
State | Published - Jul 2010 |
Keywords
- Bone
- FDG
- Metastases
- PET
ASJC Scopus subject areas
- Radiation
- Radiology Nuclear Medicine and imaging